NCT05814055

The Potential of Kava in Enabling Tobacco Cessation - Its Holistic Effects in Managing Stress and Insomnia Associated With Abstinence

Name: Clinical Trial NCT05814055
Creator: University of Florida
Keywords: Smoking, AB-free kava, Phase 2, drug, clinical trial

University of Florida·Phase 2·ClinicalTrials.gov·drugNot yet recruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Smoking
Drug/Device/Intervention: AB-free kava
Study type: Interventional
Intervention type: drug

Sponsor & location

Primary sponsor: University of Florida

Timeline & enrollment

Phase: Phase 2
Start date: Aug 01, 2023
End date: Jun 01, 2026
Enrollment: 75 participants

Primary outcome

Subject Compliance with Intervention,Subject Compliance with Intervention

Summary

This study will evaluate the compliance with a daily kava regimen among active smokers who have an intention to quit smoking. This study will also investigate whether kava use can facilitate tobacco cessation, reduce stress, and improve sleep.

ICD-10 classifications

Tobacco useExposure to tobacco smokeToxic effect: Tobacco and nicotineMental and behavioural disorders due to use of tobacco : harmful useDrug use

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT05814055
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT05814055 through Pure Global AI's free database. This Phase 2 trial is sponsored by University of Florida and is currently Not yet recruiting. The study focuses on Smoking. Target enrollment is 75 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.